感染性并发症与免疫疗法：旧有陷阱与新视野 - Suppr

Infectious complications and immunotherapy: old pitfalls and new horizons.

作者信息

Lasagna Angioletta, Cassaniti Irene, Sacchi Paolo, Baldanti Fausto, Bruno Raffaele, Pedrazzoli Paolo

机构信息

Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, 27100, Italy.

Microbiology & Virology Department, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, 27100, Italy.

出版信息

Future Oncol. 2022 Jul;18(22):2377-2381. doi: 10.2217/fon-2022-0277. Epub 2022 Jun 9.

DOI:10.2217/fon-2022-0277

PMID:35678614

Abstract

摘要

相似文献

Infectious complications and immunotherapy: old pitfalls and new horizons.

Future Oncol. 2022 Jul;18(22):2377-2381. doi: 10.2217/fon-2022-0277. Epub 2022 Jun 9.

Corticosteroids for the management of immune-related adverse events in patients receiving checkpoint inhibitors.

J Oncol Pharm Pract. 2019 Apr;25(3):544-550. doi: 10.1177/1078155217744872. Epub 2017 Dec 9.

Characteristics of hospitalizations among patients receiving immune checkpoint inhibitors at a community teaching hospital.

J Oncol Pharm Pract. 2020 Jan;26(1):60-66. doi: 10.1177/1078155219836155. Epub 2019 Mar 29.

Clin Immunol. 2020 Apr;213:108377. doi: 10.1016/j.clim.2020.108377. Epub 2020 Mar 2.

Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer.

Molecules. 2022 Jun 13;27(12):3798. doi: 10.3390/molecules27123798.

Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update.

Int J Clin Oncol. 2018 Jun;23(3):410-420. doi: 10.1007/s10147-018-1259-6. Epub 2018 Mar 7.

The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry.

Eur J Cancer. 2021 Nov;158:217-224. doi: 10.1016/j.ejca.2021.08.048. Epub 2021 Oct 7.

[Immunotherapy - immune-related adverse events and their management].

Ther Umsch. 2019 Sep;76(4):195-198. doi: 10.1024/0040-5930/a001084.

Upcoming innovations in lung cancer immunotherapy: focus on immune checkpoint inhibitors.

Chin Clin Oncol. 2015 Dec;4(4):48. doi: 10.3978/j.issn.2304-3865.2015.12.06.

Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?

Eur J Cancer. 2019 Nov;122:72-90. doi: 10.1016/j.ejca.2019.07.014. Epub 2019 Oct 18.

引用本文的文献

Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination.

Vaccines (Basel). 2024 Feb 28;12(3):252. doi: 10.3390/vaccines12030252.

The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy.

Hum Vaccin Immunother. 2023 Dec 15;19(3):2288282. doi: 10.1080/21645515.2023.2288282. Epub 2023 Dec 1.

SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors.

Cell Death Dis. 2023 Jun 30;14(6):390. doi: 10.1038/s41419-023-05922-w.

Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study.

Front Oncol. 2023 Jan 24;13:1044098. doi: 10.3389/fonc.2023.1044098. eCollection 2023.

Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions.

Front Immunol. 2022 Oct 25;13:1018202. doi: 10.3389/fimmu.2022.1018202. eCollection 2022.

Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM).

ESMO Open. 2022 Aug;7(4):100548. doi: 10.1016/j.esmoop.2022.100548. Epub 2022 Jul 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Infectious complications and immunotherapy: old pitfalls and new horizons.

作者信息

Lasagna Angioletta, Cassaniti Irene, Sacchi Paolo, Baldanti Fausto, Bruno Raffaele, Pedrazzoli Paolo

机构信息

Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, 27100, Italy.

Microbiology & Virology Department, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, 27100, Italy.

出版信息

Future Oncol. 2022 Jul;18(22):2377-2381. doi: 10.2217/fon-2022-0277. Epub 2022 Jun 9.

DOI:10.2217/fon-2022-0277

PMID:35678614

Abstract

摘要

相似文献

Infectious complications and immunotherapy: old pitfalls and new horizons.

Future Oncol. 2022 Jul;18(22):2377-2381. doi: 10.2217/fon-2022-0277. Epub 2022 Jun 9.

Corticosteroids for the management of immune-related adverse events in patients receiving checkpoint inhibitors.

J Oncol Pharm Pract. 2019 Apr;25(3):544-550. doi: 10.1177/1078155217744872. Epub 2017 Dec 9.

Characteristics of hospitalizations among patients receiving immune checkpoint inhibitors at a community teaching hospital.

J Oncol Pharm Pract. 2020 Jan;26(1):60-66. doi: 10.1177/1078155219836155. Epub 2019 Mar 29.

Clin Immunol. 2020 Apr;213:108377. doi: 10.1016/j.clim.2020.108377. Epub 2020 Mar 2.

Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer.

Molecules. 2022 Jun 13;27(12):3798. doi: 10.3390/molecules27123798.

Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update.

Int J Clin Oncol. 2018 Jun;23(3):410-420. doi: 10.1007/s10147-018-1259-6. Epub 2018 Mar 7.

The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry.

Eur J Cancer. 2021 Nov;158:217-224. doi: 10.1016/j.ejca.2021.08.048. Epub 2021 Oct 7.

[Immunotherapy - immune-related adverse events and their management].

Ther Umsch. 2019 Sep;76(4):195-198. doi: 10.1024/0040-5930/a001084.

Upcoming innovations in lung cancer immunotherapy: focus on immune checkpoint inhibitors.

Chin Clin Oncol. 2015 Dec;4(4):48. doi: 10.3978/j.issn.2304-3865.2015.12.06.

Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?

Eur J Cancer. 2019 Nov;122:72-90. doi: 10.1016/j.ejca.2019.07.014. Epub 2019 Oct 18.

引用本文的文献

Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination.

Vaccines (Basel). 2024 Feb 28;12(3):252. doi: 10.3390/vaccines12030252.

The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy.

Hum Vaccin Immunother. 2023 Dec 15;19(3):2288282. doi: 10.1080/21645515.2023.2288282. Epub 2023 Dec 1.

SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors.

Cell Death Dis. 2023 Jun 30;14(6):390. doi: 10.1038/s41419-023-05922-w.

Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study.

Front Oncol. 2023 Jan 24;13:1044098. doi: 10.3389/fonc.2023.1044098. eCollection 2023.

Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions.

Front Immunol. 2022 Oct 25;13:1018202. doi: 10.3389/fimmu.2022.1018202. eCollection 2022.

Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM).

ESMO Open. 2022 Aug;7(4):100548. doi: 10.1016/j.esmoop.2022.100548. Epub 2022 Jul 16.

Infectious complications and immunotherapy: old pitfalls and new horizons.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Infectious complications and immunotherapy: old pitfalls and new horizons.

作者信息

机构信息

出版信息

相似文献

引用本文的文献